Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologyCurative NSTEMI Coverage Policy Update | OpenPayer
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    ModifiedCurativePolicy CHP-IP-2026-002

    Acute Myocardial Infarction - NSTEMI / Unstable Angina

    Customize your policy alerts

    Sign up for curative Policy CHP-IP-2026-002 alerts

    Get alerted when Policy CHP-IP-2026-002 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity for acute inpatient admission, observation or outpatient management, level-of-care assignment, continued stay, and discharge readiness for adults with NSTEMI, type 2 myocardial infarction, unstable angina, or acute chest pain undergoing evaluation for acute coronary syndrome. It applies to Curative commercial PPO and EPO members in fully insured, level-funded, and self-funded plans.

    Policy Summary
    PayerCurative
    PolicyAcute Myocardial Infarction - NSTEMI / Unstable Angina
    Policy CodePolicy CHP-IP-2026-002
    Change TypeModified
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit criteria-based authorization requests for acute inpatient admission, continued stay, and level of care.
    SourceLink
    POLICY UPDATE CHANGES

    Routine upstream glycoprotein IIb/IIIa inhibition was removed as an inpatient service because current guidance does not recommend routine use.

    Adults 18+Applicable population
    2-3 daysExpected stay: uncomplicated NSTEMI
    1-2 daysExpected stay: unstable angina
    Every 24hContinued-stay review
    GRACE >140High-risk threshold

    Medical Necessity and Level-of-Care Criteria

    Inpatient admission

    Covered acute inpatient admission when ALL of the following are met.

    • Clinical-severity finding: At least one of the following is present: type 1 NSTEMI with troponin rise and/or fall, at least one value above the 99th-percentile upper reference limit, and ischemic symptoms or ECG changes; new dynamic horizontal or downsloping ST depression of at least 0.5 mm in 2 contiguous leads, or T-wave inversion greater than 1 mm in 2 contiguous leads with a prominent R wave; rest angina lasting more than 20 minutes, recurrent angina despite initial anti-ischemic therapy, or crescendo angina with high-risk features; GRACE score above 140, TIMI score of 3 or more, or HEART score of 7 or more; hemodynamic instability with systolic blood pressure below 90 mm Hg, acute heart failure, new or worsening mitral regurgitation, or sustained ventricular arrhythmia; or type 2 myocardial infarction with an underlying cause that itself requires inpatient treatment.
    • Hospital-level service: At least one of the following is required: invasive coronary angiography planned during hospitalization; parenteral anticoagulation; intravenous nitroglycerin; continuous ECG monitoring; intravenous diuretics, vasoactive drugs, or noninvasive ventilation for associated heart failure; or inpatient treatment of the precipitating condition for type 2 myocardial infarction.

      Angiography is planned within 2 hours for very high-risk features, within 24 hours for GRACE above 140 or other high-risk features, or before discharge for intermediate risk.

    Policy Summary
    PayerCurative
    PolicyAcute Myocardial Infarction - NSTEMI / Unstable Angina
    Policy CodePolicy CHP-IP-2026-002
    Change TypeModified
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit criteria-based authorization requests for acute inpatient admission, continued stay, and level of care.
    SourceLink
    On This Page
    Medical Necessity and Level-of-Care CriteriaDiagnosis, Procedure, Revenue, and Risk-Score CodingAuthorization and Documentation RequirementsClinical ContextClinical Definitions and Risk Concepts

    Observation or outpatient management

    Observation or emergency-department discharge with outpatient follow-up is appropriate when ANY of the following applies.

    Lower-acuity disposition: Low-risk chest pain with HEART score 0-3, high-sensitivity troponin below the myocardial-infarction threshold on a validated 0/1-hour, 0/2-hour, or 0/3-hour protocol, and no ischemic ECG changes; intermediate risk with negative serial troponins, a non-ischemic ECG, resolved symptoms, and testing needs that cannot be promptly met as an outpatient; chronic stable, non-dynamic troponin elevation without new ischemic symptoms or ECG changes; or myocardial injury without ischemia managed under another primary policy.

    Observation evaluation is generally completed within 24-48 hours.

    Intensive care unit

    ICU or cardiac ICU care is medically necessary when ANY of the following is present.

    ICU level of care: Cardiogenic shock at SCAI stage C-E or any vasopressor or inotrope requirement; refractory angina despite maximal medical therapy while awaiting immediate angiography; sustained ventricular tachycardia, ventricular fibrillation, or high-grade atrioventricular block with hemodynamic compromise; acute pulmonary edema requiring invasive ventilation or noninvasive ventilation that is not improving within 1-2 hours; or a mechanical complication or temporary mechanical circulatory support.

    Step-down or intermediate care

    Step-down or telemetry-unit care is medically necessary when no ICU criterion is met and ANY of the following is present.

    Intermediate level of care: Ongoing or recent ischemic symptoms or dynamic ECG changes requiring continuous monitoring; continuous intravenous heparin, intravenous nitroglycerin, or intravenous antiplatelet infusion; heart failure requiring intravenous diuretics with frequent reassessment or improving noninvasive ventilation; non-sustained ventricular tachycardia or new atrial fibrillation requiring rate-control titration; or the first 12-24 hours after complex PCI or observation of a femoral-access complication.

    Medical-surgical unit

    Medical-surgical unit care is appropriate when continued acute care is needed but no ICU or step-down criterion is met, including ANY of the following.

    Medical-surgical level of care: The member is hemodynamically stable and pain-free while awaiting in-hospital angiography within the next 24-48 hours; requires post-angiography telemetry only for surveillance, transition to oral therapy, or monitoring of renal function after contrast; or requires treatment of the precipitating condition for type 2 myocardial infarction that does not itself require monitored care.

    Discharge readiness

    Discharge is medically necessary when ALL of the following are met.

    Discharge readiness: Troponin has peaked and is declining or is at baseline, with no ischemic chest pain for at least 12-24 hours; the member is hemodynamically stable without intravenous vasoactive therapy; no high-grade or sustained arrhythmia has occurred for at least 24 hours; invasive evaluation is completed, or an ischemia-guided strategy is selected with risk stratification completed or scheduled within 72 hours of discharge; left ventricular ejection fraction has been assessed during the admission or within the prior 6 months without interval change; guideline-directed therapy has been started or contraindications documented, including aspirin, P2Y12 inhibitor when indicated, high-intensity statin, beta-blocker when indicated, and renin-angiotensin system inhibitor when ejection fraction is 40% or less or hypertension, diabetes, or chronic kidney disease is present; the member is ambulatory without symptoms, the access site is intact, and hemoglobin and creatinine are stable; and a safe transition plan is in place, including education, cardiac rehabilitation referral for NSTEMI or revascularized unstable angina, and follow-up within 1-2 weeks.Systolic blood pressure at least 90 mm Hg; resting heart rate 50-110 beats per minute.

    Continued-stay criteria

    Continued acute inpatient stay is medically necessary, with review every 24 hours, when ANY of the following is documented.

    Continued-stay trigger: Clinically indicated in-hospital angiography is pending with a documented reason for any delay longer than 24 hours; multivessel or left-main disease is awaiting a heart-team decision or CABG during the same admission; recurrent ischemia, reinfarction, or new heart failure is present; arrhythmia requires intravenous therapy or monitoring of a new rhythm-control drug; an access-site complication or acute kidney injury requires daily management; or the precipitating condition for type 2 myocardial infarction still requires inpatient treatment.Review every 24 hours.

    A stable member awaiting routine scheduling over a weekend is reviewed for level of care.

    Extended-stay review

    Extended-stay review applies when the stay exceeds the expected benchmark and ANY trigger is present.

    Extended-stay trigger: Persistent hemodynamic instability or vasoactive support; refractory arrhythmia; recurrent ischemia or new biomarker rise; access-site bleeding requiring transfusion; contrast-associated acute kidney injury delaying angiography or requiring monitoring; CABG during the same admission; or up-titration of therapy limited by hypotension or worsening renal function.Review every 24 hours.

    Expected length of stay is a planning benchmark, not a limit on covered days. The expected stay is about 2-3 days for uncomplicated NSTEMI managed with an early invasive strategy and 1-2 days for unstable angina.

    Does not meet criteria

    The following circumstances do not meet medical-necessity criteria and are referred for physician review.

    Does not meet criteria: Inpatient admission for chest pain with HEART score 0-3, a negative high-sensitivity troponin protocol, and a non-ischemic ECG; inpatient admission solely for stable, chronically elevated, non-dynamic troponin without new ischemic findings; continued stay solely for stress testing or coronary CT angiography that could be completed within 72 hours as an outpatient in a stable member; routine glycoprotein IIb/IIIa inhibitor infusion as the only hospital-level service in a stable member; or days awaiting post-acute placement after discharge-readiness criteria are met without an acute need.

    These requests are not denied by an automated system or a non-physician reviewer.

    STEMI is outside the scope of this policy and is managed under Policy A001.

    Acute heart failure without acute coronary syndrome is outside the scope of this policy and is managed under Policy A003.

    Atrial fibrillation as the primary problem is outside the scope of this policy and is managed under Policy A005.

    If new ST elevation or a STEMI-equivalent develops during the stay, manage the case as STEMI under Policy A001 with emergent reperfusion rather than routine NSTEMI or unstable-angina management.

    Inpatient admission is not supported for low-risk chest pain when the HEART score is 0-3, a validated high-sensitivity troponin protocol is negative, and the ECG is non-ischemic. Observation or outpatient management with follow-up is appropriate.

    A stable, chronically elevated, non-dynamic troponin level without new ischemic symptoms or findings does not, by itself, support acute inpatient care.

    A continued inpatient stay solely for stress testing or coronary CT angiography does not meet criteria when the testing can be completed within 72 hours as an outpatient in a stable member.

    Routine upstream glycoprotein IIb/IIIa inhibitor infusion does not support inpatient care when it is the only hospital-level service for a stable member.

    Custodial days spent awaiting post-acute placement after discharge-readiness criteria are met, without an acute need, do not meet acute-care criteria. These cases are referred for physician review and discharge planning.

    Diagnosis, Procedure, Revenue, and Risk-Score Coding

    ICD-10-CM: NSTEMI and other myocardial infarction typesICD-10
    I21.4NSTEMI and other myocardial infarction types
    I21.9NSTEMI and other myocardial infarction types
    I21.A1NSTEMI and other myocardial infarction types
    I21.A9NSTEMI and other myocardial infarction types
    I21.BNSTEMI and other myocardial infarction types
    ICD-10-CM: unstable and other anginaICD-10
    I20.0Unstable and other angina
    I20.1Unstable and other angina
    I20.2Unstable and other angina
    I20.81Unstable and other angina
    I20.89Unstable and other angina
    I20.9Unstable and other angina
    ICD-10-PCS: percutaneous coronary intervention examplesICD-10
    02703ZZPercutaneous coronary intervention (example)
    027034ZPercutaneous coronary intervention (example)
    027134ZPercutaneous coronary intervention (example)
    MS-DRG: acute myocardial infarction, discharged alivemixed
    280Acute myocardial infarction, discharged alive
    281Acute myocardial infarction, discharged alive
    282Acute myocardial infarction, discharged alive
    MS-DRG: angina and circulatory disorders with catheterizationmixed
    286Angina and circulatory disorders with catheterization
    287Angina and circulatory disorders with catheterization
    311Angina and circulatory disorders with catheterization
    MS-DRG: percutaneous cardiovascular proceduresmixed
    250Percutaneous cardiovascular procedures
    251Percutaneous cardiovascular procedures
    321Percutaneous cardiovascular procedures
    322Percutaneous cardiovascular procedures
    323Percutaneous cardiovascular procedures
    324Percutaneous cardiovascular procedures
    325Percutaneous cardiovascular procedures
    MS-DRG: coronary bypassmixed
    231Coronary bypass
    232Coronary bypass
    233Coronary bypass
    234Coronary bypass
    235Coronary bypass
    236Coronary bypass
    Revenue codesRevenue
    0120Revenue code
    0121Revenue code
    0122Revenue code
    0123Revenue code
    0124Revenue code
    0126Revenue code
    0127Revenue code
    0128Revenue code
    0129Revenue code
    0200Revenue code
    1–10 of 78
    1/8
    Applicable Revenue CodesRevenueCovered
    0120Revenue code
    0121Revenue code
    0122Revenue code
    0123Revenue code
    0124Revenue code
    0126Revenue code
    0127Revenue code
    0128Revenue code
    0129Revenue code
    0200Revenue code
    1–10 of 78
    1/8
    HEART score
    Low-risk rangeHEART score 0-3
    High-risk thresholdHEART score 7 or more
    Score componentsHistory, ECG, Age, Risk factors, and Troponin
    GRACE score
    High-risk thresholdGRACE score above 140
    Invasive-care timingEarly coronary angiography within 24 hours for GRACE above 140 or other high-risk features
    Risk assessment useSupports timing decisions for invasive care in non-ST-elevation acute coronary syndrome
    TIMI score
    Score rangeTIMI score 0-7
    Low-risk rangeTIMI score 0-2
    Inpatient-severity thresholdTIMI score 3 or more
    Systolic blood pressure
    Instability thresholdSystolic blood pressure below 90 mm Hg
    Clinical significanceIndicates hemodynamic instability
    Admission relevanceQualifying clinical severity finding for acute inpatient admission
    Dynamic ECG changes
    ST-depression thresholdNew horizontal or downsloping ST depression of at least 0.5 mm in 2 contiguous leads
    T-wave thresholdT-wave inversion greater than 1 mm in 2 contiguous leads with a prominent R wave
    Required characteristicThe ECG change must be dynamic
    Discharge stability
    Chest-pain stabilityNo ischemic chest pain for at least 12-24 hours
    Rhythm stabilityNo high-grade or sustained arrhythmia for at least 24 hours
    Hemodynamic stabilitySystolic blood pressure at least 90 mm Hg without intravenous vasoactive therapy
    Resting heart rate50-110 beats per minute
    Transition requirementsInvasive evaluation completed or an ischemia-guided strategy selected; the member is ambulatory without symptoms, laboratory values are stable, and follow-up is arranged within 1-2 weeks
    GRACE score
    ThresholdGRACE score above 140
    Risk categoryHigh risk
    Clinical applicationSupports early invasive evaluation and coronary angiography within 24 hours when applicable

    Authorization and Documentation Requirements

    Prior Authorization

    Submit criteria-based inpatient authorization

    Submit authorization requests for acute inpatient admission, continued stay, and level of care with documentation demonstrating the applicable medical-necessity criteria. Inpatient admission requires at least one qualifying clinical-severity finding and at least one required hospital-level service; continued stay requires an active qualifying condition reviewed every 24 hours.

    • Clinical-severity findings may include qualifying troponin changes with ischemic symptoms or ECG changes, dynamic ischemic ECG changes, high-risk scores, hemodynamic instability, acute heart failure, sustained ventricular arrhythmia, or a type 2 myocardial infarction requiring inpatient treatment.
    • Hospital-level services may include planned invasive coronary angiography, parenteral anticoagulation, intravenous nitroglycerin, continuous ECG monitoring, or inpatient treatment for associated heart failure or the precipitating condition of type 2 myocardial infarction.
    Prior Authorization

    Support the requested level of care

    Assign ICU, step-down/telemetry, or medical-surgical care according to the applicable level-of-care criteria. ICU care requires at least one ICU trigger; step-down care requires no ICU trigger plus at least one intermediate-care trigger; medical-surgical care is appropriate when acute care remains necessary but higher-level criteria are absent.

    • ICU triggers include cardiogenic shock, vasopressor or inotrope use, refractory angina awaiting immediate angiography, hemodynamically compromising ventricular arrhythmia or high-grade AV block, nonimproving pulmonary edema requiring ventilation, or mechanical circulatory support.
    • Step-down or telemetry triggers include ongoing or recent ischemia requiring monitoring, continuous intravenous heparin, nitroglycerin, or antiplatelet infusion, heart failure requiring intravenous diuretics, selected arrhythmias, or the first 12-24 hours after complex PCI.
    Documentation Required

    Document discharge readiness

    Before discharge, document that all discharge-readiness requirements are met, including clinical stability and completion or scheduling of invasive or ischemia-guided evaluation. Include the transition plan, required therapy or documented contraindications, education, applicable cardiac rehabilitation referral, and follow-up within 1-2 weeks.

    • Troponin must be peaked and declining or at baseline, with no ischemic chest pain for at least 12-24 hours.
    • Document no high-grade or sustained arrhythmia for at least 24 hours, stable blood pressure and heart rate, assessed ejection fraction, stable hemoglobin and creatinine, and ambulation without symptoms.
    Documentation Required

    Required clinical documentation

    Include the clinical record elements needed to substantiate the diagnosis, risk level, treatment strategy, and requested care. Missing supporting documentation can prevent confirmation of medical necessity or the appropriate level of care.

    • Serial ECGs with timestamps.
    • Troponin values with assay type, 99th-percentile limit, and timing of each sample.
    • Documented HEART, TIMI, or GRACE score and risk category.
    • Selected invasive or ischemia-guided strategy and timing rationale.
    • Catheterization and revascularization information or stress/CT angiography results.
    • Ejection fraction, daily level-of-care justification, medication reconciliation, and discharge follow-up plan.
    Documentation Required

    Continued-stay and extended-stay support

    For continued stays and days beyond the expected length of stay, document the active clinical trigger, objective supporting evidence, and treatment plan, with review at least every 24 hours. Any angiography delay longer than 24 hours requires a documented reason.

    • Continued-stay triggers include recurrent ischemia or reinfarction, new heart failure, arrhythmia requiring intravenous therapy, access-site complications, acute kidney injury requiring daily management, or a type 2 myocardial infarction precipitating condition still requiring inpatient treatment.
    • Extended-stay triggers include persistent hemodynamic instability, refractory arrhythmia, recurrent ischemia or new biomarker rise, access-site bleeding requiring transfusion, contrast-associated acute kidney injury, CABG during the same admission, or therapy up-titration limited by hypotension or worsening renal function.
    • Expected length of stay is a planning benchmark, not a limit on covered days.
    Billing Rule

    Support requested quantity and duration

    Ensure that the requested quantity, units, and duration are supported by the submitted documentation. If the documentation supports only part of the request, the supported portion is approved and only the unsupported increment is reviewed.

    • Document the clinical basis for each requested inpatient period or unit of service.
    • Concurrent review applies to each continued-stay period.
    Denial Risk

    Low-risk or inappropriate site of care

    Do not request inpatient admission or continued inpatient care for low-risk presentations that meet observation or outpatient criteria. Low-risk chest pain with HEART score 0-3, a negative high-sensitivity troponin protocol, and a non-ischemic ECG does not support inpatient admission; stable chronic non-dynamic troponin without new ischemic findings and testing that can be completed outpatient within 72 hours likewise do not support the requested care.

    • Consider observation or emergency-department discharge with outpatient follow-up when the applicable lower-acuity criteria are met.
    • Stable chronic troponin elevation without new ischemic findings does not by itself establish an acute inpatient need.
    Denial Risk

    Routine upstream antiplatelet infusion

    Do not use routine glycoprotein IIb/IIIa inhibitor infusion as the sole basis for inpatient care in a stable member. Routine upstream glycoprotein IIb/IIIa therapy is not a qualifying hospital-level service by itself.

    • Document other qualifying clinical-severity findings and hospital-level services when inpatient care is requested.
    Denial Risk

    Custodial or post-discharge placement days

    Do not continue acute inpatient days solely because post-acute placement is delayed after discharge-readiness criteria are met. Days awaiting placement without an acute need do not meet acute-care criteria and require discharge planning and physician review.

    • Days already authorized are not retroactively denied.
    Prior Authorization

    STEMI conversion

    If new ST elevation or a STEMI-equivalent develops during the stay, manage the member as STEMI under Policy A001 with emergent reperfusion rather than routine NSTEMI or unstable-angina handling.

    • The finding changes the review pathway and requires urgent STEMI management.
    Denial Risk

    Unsafe discharge

    Do not discharge a member with ongoing ischemia, uncontrolled arrhythmia, or rising creatinine at the planned discharge time. Discharge is unsafe in these circumstances and acute care must continue.

    • Reassess discharge readiness when ischemia, rhythm instability, or renal deterioration is present.
    Prior Authorization

    Requests failing criteria require physician review

    Requests that do not meet the policy criteria must be referred for physician review rather than receiving an adverse determination from an automated system or non-physician reviewer.

    • Automated systems and non-physician clinical reviewers may approve a request in full or in part but may not issue an adverse determination.
    Prior Authorization

    Physician adverse-determination process

    Only a licensed physician of the same or similar specialty may issue an adverse determination. The requesting provider must first be offered a peer-to-peer discussion, and the reviewing physician must meet applicable plan and state requirements.

    • The physician review process applies when a request does not meet criteria or when the unsupported portion of a quantity, unit, or duration is reviewed.
    • A service is not subject to adverse determination solely because the policy does not address a specific criterion; the request must be reviewed by a physician applying generally accepted standards of medical practice.

    Clinical Context

    Non-ST-elevation acute coronary syndromes span a broad clinical spectrum, from low-risk unstable angina that may be evaluated in observation or outpatient settings using high-sensitivity troponin protocols and structured risk scores, to NSTEMI with refractory ischemia, heart failure, or shock requiring immediate invasive management. The policy uses risk-based pathways to guide disposition and the timing of invasive evaluation.

    Clinical Definitions and Risk Concepts

    NSTEMI
    Troponin findingA rise and/or fall of cardiac troponin with at least one value above the 99th-percentile upper reference limit
    Ischemic evidenceClinical evidence of ischemia
    ECG distinctionNo persistent ST elevation
    Type 2 myocardial infarction
    MechanismOxygen supply-demand imbalance rather than atherothrombotic plaque disruption
    Examples of precipitating conditionsTachyarrhythmia, anemia, hypotension, or hypoxemia
    Clinical implicationThe underlying cause determines whether inpatient treatment is required
    Unstable angina
    SymptomsIschemic chest discomfort at rest, of new onset, or with a crescendo pattern
    Troponin findingNo troponin elevation above the myocardial-infarction threshold
    Distinction from NSTEMIIschemic symptoms are present without myocardial-infarction-level troponin elevation
    HEART score
    Score rangeValidated 0-10 chest-pain risk score
    ComponentsHistory, ECG, Age, Risk factors, and Troponin
    Low-risk rangeHEART score 0-3
    GRACE score
    Full nameGlobal Registry of Acute Coronary Events risk score
    High-risk thresholdA GRACE score above 140 identifies high risk
    Clinical useUsed to support risk-based timing of invasive care
    TIMI risk score
    Score rangeSeven-item score from 0-7
    Applicable conditionsUnstable angina and NSTEMI
    Low-risk rangeTIMI score 0-2
    Myocardial injury versus myocardial infarction
    Myocardial infarctionRequires distinction from chronic or non-ischemic myocardial injury and is defined in the policy by ischemic context and infarction criteria
    Type 2 infarctionA distinct myocardial infarction category caused by oxygen supply-demand imbalance
    Chronic stable troponinChronically elevated, stable troponin without ischemia does not by itself justify admission